About the role
Full job description is available on the company's career page. View on company site →
Skills & Tags
Aplyr's read
Gilead Sciences is a leader in antiviral drug development, attracting professionals committed to advancing treatments for HIV, hepatitis, and other critical diseases.
What's promising
- •Strong focus on antiviral drugs with a proven track record in HIV and hepatitis treatment.
- •Recent expansion into oncology and cell therapy indicates growth and diversification.
- •Robust pipeline of innovative medicines addressing unmet medical needs.
What to watch
- •High dependency on a few blockbuster drugs for revenue.
- •Regulatory challenges and pricing pressures in the pharmaceutical industry.
- •Potential for increased competition in the antiviral drug market.
Why Gilead Sciences
- •Pioneering role in developing antiviral therapies, particularly for HIV and hepatitis.
- •Integration of advanced technologies in research, such as AI for drug discovery.
- •Strategic expansion into oncology and cell therapy through acquisitions like Kite Pharma.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, with a focus on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza.
Similar roles
Executive Director, Global Commercial Lead
Revolution Medicines
Executive Director, Global WPP Network Growth
VML Enterprise Solutions
Global Network Growth Executive Director
VML (Wunderman Thompson)
Global Network Growth Executive Director
VML (Wunderman Thompson)
US Executive Branch Lead, Global Affairs
OpenAI